Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × perifosine × Sarcoma × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Myeloid 2 Lymphoid 2 Genitourinary 2 Sarcoma 1 Head & Neck 1 Gastrointestinal 1

Conditions

Interventions

Radiotherapy 39 Temozolomide 31 Magnetic Resonance Spectroscopy 31 Doxorubicin 30 Cyclophosphamide 30 Specimen Handling 29 Vincristine 23 Etoposide 20 Radiation 19 Filgrastim 18 Biopsy 18 Ifosfamide 17 Bevacizumab 15 X-Rays 12 Sirolimus 12 Nivolumab 12 temsirolimus 11 Sorafenib 11 Ipilimumab 11 Imatinib Mesylate 11 Carboplatin 11 Surgical Procedures, Operative 10 Methotrexate 10 Irinotecan 10 Radiotherapy, Conformal 9 Peripheral Blood Stem Cell Transplantation 9 Immunoglobulin G 9 Disulfides 9 CTLA-4 Antigen 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00064324 2013-06-04

Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡